Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Eli Lilly and Company (LLY)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eli Lilly's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
746.56 -4.21    -0.56%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
746.25
-0.31
-0.04%
19:30:27 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,375,116
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 743.03 - 753.14
Eli Lilly 746.56 -4.21 -0.56%

Eli Lilly and Company Company Profile

 
Get an in-depth profile of Eli Lilly and Company, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

39000

Equity Type

ORD

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Contact Information

Address Lilly Corporate Center
Indianapolis, 46285
United States
Phone 317 276 2000
Fax -
Web www.lilly.com

Top Executives

Name Age Since Title
Sidney Taurel 72 1991 Chairman Emeritus
David A. Ricks 53 2012 Chairman, CEO & President
Carolyn R. Bertozzi 54 2017 Independent Director
William G. Kaelin 64 2012 Independent Director
Marschall S. Runge 68 2013 Independent Director
Ralph Alvarez 67 2009 Independent Director
Katherine Baicker 50 2011 Independent Director
J. Erik Fyrwald 63 2005 Independent Director
Jamere Jackson 54 2016 Independent Director
Juan Ricardo Luciano 62 2016 Lead Independent Director
Karen M. Walker 61 2018 Independent Director
Kimberly H. Johnson 50 2021 Independent Director
Mary Lynne Hedley 60 2022 Independent Director
Gabrielle E. Greene-Sulzberger 63 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

LLY Comments

Write your thoughts about Eli Lilly and Company
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Morey
Mike Morey Feb 24, 2024 11:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
so happy the I hold this stock. and have for sometime now. LETS GOOOO
Reply
6 3
Report
damian del
mudlog79 Feb 24, 2024 11:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
comment so gay
Reply
3 0
Report
Eddie Keegan
Eddie Keegan Feb 21, 2024 9:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this is a hugeeeeee mover outside of the AI frenzy that hardly gets attention.
Reply
8 2
Report
Shah King
Shah King Feb 20, 2024 7:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how come no one is commenting on it ? until a strong competitor comes or major frequent adverse effects gets reported, this ain't goin down
Reply
5 2
Report
D Petersen
D Petersen Feb 16, 2024 5:20PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Near $900 will be the time to load up on 3 to 6 month puts.
Reply
2 1
Report
damian del
mudlog79 Feb 16, 2024 4:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
stupid bubble, childish
Reply
1 3
Report
Colter Bauman
Colter Bauman Feb 16, 2024 4:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
mate, it isn't gonna pop, at least until some competitor comes
Reply
0 0
Report
Mel Straub
Mel Straub Feb 16, 2024 3:57PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
So basically when you first start taking the drug you will probably get very sick and not be able to eat but as starvation kicks in you will find that some foods don't make you sick once you know what you can eat more than likely the weight loss will stop. Good luck to anyone trying the drug.
Reply
2 1
Report
Mel Straub
Mel Straub Feb 16, 2024 3:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The shot only works for about 3 months after that you will figure out what foods you can eat and not get sick
Reply
1 0
Report
Grumpy Cat
Grumpy Cat Feb 16, 2024 10:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
After SMCI jumped off a cliff I feel like Eli is next.
Reply
2 2
Report
Grumpy Cat
Grumpy Cat Feb 16, 2024 10:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sadly it appears I might've been right. I think I might have to reinvest my money into fund managers with good records, more reliable.
Reply
1 0
Report
D Petersen
D Petersen Feb 15, 2024 11:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I double checked my signals, $882 is my major high prediction, and it should be soon, within weeks.
Reply
1 0
Report
D Petersen
D Petersen Feb 13, 2024 7:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
LLY should soon top out at $812
Reply
1 1
Report
JJ Boris
JJ Boris Feb 13, 2024 7:15PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
+900 probably will be the top
Reply
0 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email